Akari Therapeutics (AKTX) Profit After Tax (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -172.84% |
| Dec 31, 2025 | 17.22% |
| Sep 30, 2025 | -237.73% |
| Jun 30, 2025 | 48.85% |
| Mar 31, 2025 | 97.35% |
| Dec 31, 2024 | -4,735.68% |
| Sep 30, 2024 | 61.70% |
| Jun 30, 2024 | -35.79% |
| Mar 31, 2024 | -34.51% |
| Dec 31, 2023 | -44.13% |
| Sep 30, 2023 | 28.23% |
| Jun 30, 2023 | -499.60% |
| Jun 30, 2022 | -9.73% |
| Mar 31, 2022 | -144.55% |
| Dec 31, 2021 | 900.52% |
| Sep 30, 2021 | 66.61% |
| Jun 30, 2021 | 25.56% |
| Mar 31, 2021 | 14.26% |
| Dec 31, 2020 | -845.51% |
| Sep 30, 2020 | 112.28% |
| Jun 30, 2020 | 100.00% |
| Mar 31, 2020 | -47,833,808.58% |
| Dec 31, 2019 | -171.70% |
| Sep 30, 2019 | 51.55% |
| Jun 30, 2019 | -333.68% |
| Mar 31, 2019 | 172.46% |
| Dec 31, 2018 | 2.24% |
| Sep 30, 2018 | 55.21% |
| Jun 30, 2018 | -499.31% |
| Mar 31, 2018 | 88.95% |
| Dec 31, 2017 | -16.78% |
| Sep 30, 2017 | -3,142.52% |
| Jun 30, 2017 | 97.46% |
| Mar 31, 2017 | -51.87% |
| Dec 31, 2016 | -1,881.78% |
| Sep 30, 2016 | 93.52% |
| Jun 30, 2016 | -116.10% |
| Mar 31, 2016 | -146.13% |
| Dec 31, 2015 | 113.28% |
| Sep 30, 2015 | -3,534.91% |
| Jun 30, 2015 | 20.98% |
| Mar 31, 2015 | -52.34% |
| Dec 31, 2014 | -399.18% |
| Sep 30, 2014 | 89.99% |
| Jun 30, 2014 | -28.10% |